Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The fact that the CDC granted a meeting with Halberd Corporation and is willing to work with them is a level of validation that few companies achieve. My guess is this will be one of hopefully many meetings with the CDC and that they will both be willing to move forward with the procedures Halberd Corporation is working on.
Less than one week now till their big meeting with the CDC, these cheapies won't be here forever
$HALB using .012 as support. Would love to see this push back over .0134 (8 DMA) today https://schrts.co/nKvhGAwt
If you didn't buy at this price, you'll be kicking yourself when this gets above the radar.
$HALB broke above the 8 DMA yesterday. Watch for the 20 DMA test next. #bullish https://schrts.co/hsIShWnh
$HALB This under-the-radar biotech stock could have the answer to the Candida Auris Fungus Breakout!
https://thestreetreports.com/halberd-corp-otchalb-may-hold-the-key-in-candida-auris-fungus-breakout/
$HALB broke above the 8 DMA yesterday. Watch for the 20 DMA test next. #bullish https://schrts.co/hsIShWnh
blood cleaned, and then get fresh nutrition and oxygen. go back school and learn more.
HALB: Make sure you read AGAIN my penultimate post here on HALB, as I have UPDATED it several times in my attempt to EDIFY both you & everyone here on the TRUTH of Human Physiology. You ALL (hopefully) must some day come to UNDERSTAND that we Humans become infected AND die on this Planet by only ONE SINGULAR DISEASE!!!! So, WHAT is that Disease??? To wit, the GROSS IGNORANCE of so-called "MEDICAL SCIENCE" on this Planet!!!
HALB: That "Disease" has NOTHING, per se, at all to do with Human BLOOD, Sir!!! When Septicemia infects Human BLOOD, that blood is merely ONE of the countless ORGANS & TISSUES of our Species. And even if the morons at HALB were to systematically REMOVE all arterial AND venus BLOOD from such a patient --- & then RETURN that blood to them --- that patient would STILL be infected with that disease. WHY?? Because Septicemia is a disease which INFUSES nearly every ORGAN & TISSUE of the Human BODY.
Could HALB's (primitive & senseless) "EXTRA-CORPOREAL" routine in fact KILL every single infectious MICROBE in a patient's REMOVED BLOOD??? Well, possibly! However, those SAME microbes --- which cause Septicemia --- would STILL reside in HUGE NUMBERS within the ORGANS & TISSUES of such patients!!! (Are you beginning to UNDERSTAND the TRUTH of the Planet upon which you reside, Sir????)
septicemia
NOUN
blood poisoning, especially that caused by bacteria or their toxins.
By definition, septicemia is bacteria in the bloodstream.
HALB: Their (bogus) claims are so conspicuously-ABSURD, that they are merely making public spectacles of their GROSS IGNORANCE of basic Human Physiology & Disease Pathology!!! Such Bacterial, Viral, & Parasitic INFECTIONS reside in our Human ORGANS & TISSUES --- and NOT in the BLOOD!!! Even so-called Cancer-of-the-Blood (Leukemia) resides in our BONE MARROW & SPLEEN --- and NOT in the BLOOD!!!
HALB: Well, evidently, the Admins. do NOT now have me restricted to just one post per day here. So, one final comment, Peeps: Get the FBI to investigate this so-called "Company". Or, PHONE the (US) "Centers For Disease Control & Prevention", & discover for YOURSELVES that they have NOTHING (substantive at all) to do with this BULLSHIT-NONSENSE carnival sideshow.
No it's not that we can't hear you, it's just the fact that IF something comes out of it, we can make tons, is all. Remember it's not a DOW company. But could be. :)
HALB: This Company is the biggest SCAM I have ever witnessed in my 20+ years of trading!!! They have NOTHING AT ALL to do with America's Federal CDC&P, as they claimed in a PR recently.
If you believe that HALB's so-called "EXTRA-CORPOREAL" laser treatments of Blood, Spinal Fluids, inter alia, can cure ANY Human afflictions, then you believe that simply CHANGING your truck's transy, engine, & radiator FLUIDS will FIX physically-BROKEN transmissions, engines, & radiators!!!!!!!! Are you THAT stupid????????????? ALL Human Diseases & Afflictions reside within the INTERNAL ORGANS & (CORRUPTED) DNA of our BODIES!!! And NOT within the mere bodily FLUIDS therein!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! For the very last time, you have been EDIFIED!!!
PS: Many times during the past several months, I have posted here to WARN all about this conspicuously-SCAMMING firm --- but nobody listens; and, I am LIMITED by the Admins. to just ONE POST per day here.
The big difference is standard antibiotics take hours to days to eradicate bacteria. This stated to 10 minutes or less.
It varies based on the individual antibiotic but they all are around 90% as well.
The PR said OVER 90%. Do the others say OVER, too?
$HALB
HALB**Eradicates All Strains of Antibiotic Resistant E. Coli...
This is solid news for HALB to eradicates all strains of antibiotic resistant E. Coli:
90% is the same rate for standard antibiotics according to research I saw on the internet.
Yeah, but they only eradicated 90%.
WOW - PR out! Halberd is currently testing antibiotic resistant Klebsiella pneumonia strains at YSU and expects to have the testing completed prior to the meeting with the CDC.
Halberd...is pleased to report it has successfully eradicated ALL of the strains of antibiotic resistant E. coli samples previously provided by the CDC.
$HALB Halberd Eradicates All Strains of Antibiotic Resistant E. Coli Provided by the CDC at Youngstown State University
https://www.accesswire.com/744839/Halberd-Eradicates-All-Strains-of-Antibiotic-Resistant-E-Coli-Provided-by-the-CDC-at-Youngstown-State-University
JACKSON CENTER, PA / ACCESSWIRE / March 21, 2023 / Halberd Corporation (OTC PINK:HALB), leading up to the scheduled meeting with the Centers for Disease Control (CDC) on March 29, 2023, is pleased to report it has successfully eradicated all of the strains of antibiotic resistant E. coli samples previously provided by the CDC. Using Halberd's patented extracorporeal (outside the body) process and patent-pending laser eradication method in conjunction with metallic nanoparticles, over 90% of each of the bacteria strains was eradicated in under 10 minutes of process time.
Halberd is currently testing antibiotic resistant Klebsiella pneumoniae strains at Youngstown State University (YSU) and expects to have the testing completed prior to the meeting with the CDC. According to the CDC, Klebsiella pneumoniae, a Gram-negative bacteria which has developed antibiotic resistance, can cause pneumonia, blood stream infections, wound or surgical site infections, and meningitis. Gram-negative bacteria are resistant to multiple drugs and are increasingly resistant to most available antibiotics.[1]
Dr. Chester Cooper, Professor, Department of Chemical and Biological Sciences at YSU stated, "So far, we have been able to eradicate all of the antibiotic resistant E. coli strains provided and have also eradicated five strains of antibiotic resistant Candida auris fungus, and are confident that our methodology will be successful on Klebsiella strains."
Dr. W. Gregg Sturrus, Chair and Professor, Physics, Astronomy Geology and Earth Science Department added, "With each test, we gain insights into how to improve the process and generate ideas on the best way to move this technology from the laboratory to a therapeutic application."
William A. Hartman, Halberd's Chairman, President & CEO commented, "What is astounding is that Halberd has been able to eradicate such a wide variety of pathogens in a matter of minutes, compared to days with a normal course of drug treatments. And since this procedure can be conducted outside the body, the potential for adverse side-effects is minimal to non-existent.
"Halberd has assembled an outstanding team of "Halberd Heroes" who have developed our great multi-use technology and deserve a salute for their dedication. The CDC may have supplied antibiotic-resistant pathogens to Halberd, but our team has proven that those pathogens are not Halberd-resistant."
Should be a stock to watch for sure. :)
$HALB LOCK AND LOAD! BIG NEWS/UPDATES COMIHG... KEEP ON YOUR RADAR!
$HALB looking for a bounce off this bottom bollie today. Strong support at .12 yesterday. https://schrts.co/MVWDEhqW
$HALB Halberd's unparalleled successes in the eradication of antibiotic-resistant bacteria and deadly Candida Auris continue in advance of the scheduled meeting with the CDC on 3-29-23. Halberd is committed to assisting the CDC in furthering its disease eradication objectives.
$HALB Halberd's unparalleled successes in the eradication of antibiotic-resistant bacteria and deadly Candida Auris continue in advance of the scheduled meeting with the CDC on 3-29-23. Halberd is committed to assisting the CDC in furthering its disease eradication objectives. pic.twitter.com/Km0PpS8aDd
— Halberd Corporation (@HalberdC) March 16, 2023
$HALB CDC meeting on 3/29! this could run wild with positive developments from that meeting. "We are anxious to report our progress to the CDC in our meeting on March 29th." https://www.otcmarkets.com/stock/halb/news/Halberd--Centers-for-Disease-Control-to-Meet-Regarding-Eradication-of-Antibiotic-Resistant-Pathogens?id=393103
$HALB Halberd & Centers for Disease Control to Meet Regarding Eradication of Antibiotic Resistant Pathogens https://finance.yahoo.com/news/halberd-centers-disease-control-meet-120000964.html
$HALB check out this chart, golden cross is imminent! Heading to the top of my radar. https://schrts.co/BInrKQZb
$HALB Halberd's patented process demonstrates eradication of multiple strains of antibiotic resistant bacteria and fungi in under 10 minutes. Meeting set with CDC
Exactly 2 weeks until the most important landmark in the history of the company! Looking forward to great things.
$HALB Halberd & Centers for Disease Control to Meet Regarding Eradication of Antibiotic Resistant Pathogens
https://www.accesswire.com/743565/halberd--centers-for-disease-control-to-meet-regarding-eradication-of-antibiotic-resistant-pathogens
JACKSON CENTER, PA / ACCESSWIRE / March 14, 2023 / Halberd Corporation (OTC PINK:HALB) is scheduled to meet with Center of Disease Control (CDC) representatives to discuss Halberd's incredible success in eradicating multiple strains of antibiotic resistant (AR) E. coli bacteria and Candida auris samples previously provided by the CDC. The testing, currently underway at Youngstown State University (YSU) using Halberd's patented extracorporeal laser eradication process, eradicated over 90% of the AR bacteria and AR fungus, in vitro in under 10 minutes compared to up to 10 days using oral or injected antibiotics (the current standard of care).
Dr. Cooper, Professor, Department of Chemical and Biological Sciences at YSU, and Halberd's primary interface with the CDC, stated, "We are anxious to report our progress to the CDC in our meeting on March 29th."
Dr. Sturrus, Chair and Professor, Physics, Astronomy, Geology, and Environmental Science Department at YSU added, "To date, using Halberd's patented technology process, we have been successful in our in vitro laboratory tests in eradicating inflammatory cytokines associated with neurodegenerative diseases, excitatory neuro-transmitters (Glutamate) associated with head trauma, antibiotic-resistant bacteria and Candida auris in 10 minutes or less of laser irradiation. This is truly a breakthrough technology worthy of support by the scientific community."
William A. Hartman, Halberd's Chairman, President & CEO commented, "This meeting with the CDC is a tremendous opportunity for Halberd to present our incredible results to the antibiotic resistant bacteria experts at the CDC. To date, we have been able to demonstrate eradication of 12 of the 18 strains of antibiotic resistant E. coli provided by the CDC within just 10 minutes or less of laser emissive energy exposure using our patented process, and we are on track to have the remainder of the 18 strains of bacteria tested prior to our meeting with the CDC on March 29th." We have also had preliminary success with 4 of the 20 strains of candida auris provided by the CDC and will begin testing our method on the 12 strains of Klebsiella pneumoniae from the CDC.
Hartman concluded, "We will continue to contact other government agencies as well as potential partners in order to expedite the further development of our patented technology."
To get the latest news on Halberd's exciting developments, including our ongoing disease eradication accomplishments, subscribe by submitting this form.
(https://halberdcorporation.com/contact-us/)
Good news! Meeting definitively scheduled with the CDC and $HALB on March 29th. Getting serious.
Good news! Meeting definitively scheduled with the CDC and $HALB on March 29th. Getting serious.
When this breaks on the 10 oc news, we go to the moon.
Expect a lot of news this month
$HALB still experimenting on 30 strains of antibiotic resistant bacteria donated by the CDC; especially the results killing Candida Auris (deadly) and Shigella (CDC sounded the alarm last week) very interesting and might lead to partnership with CDC and funding
Animal testing (nasal spray to treat brain trauma) starts at Mississippi State University, PR upcoming
No dilution since 08/16/2021
Is that sarcasm? A tweet is getting serious? LMAO
$HALB referenced in a tweet today an upcoming meeting with the CDC! Sounds like things are getting serious.
Yes it was ....years ago. Not anymore. Too many other people involved now. CDC, Universities (more than one), Million dollar grants. They got their s___t together and I got my shares.
(responsible mod: Bill Moynihan/EHRjunkie)
Halberd Corp. (OTC PINK:HALB), is a publicly traded company on the OTC Market, and is in full compliance with OTC Market reporting requirements.
Halberd holds the exclusive rights to 4 granted U.S. Patents, no. 9,216,386 no. 8,758,287 and no. 11,186,629, no. 8,865,733
Halberd Corporation is a biotechnology company and with its partners (Dr. Qiang Shawn Chen and his team at Arizona State University; Dr. William Sturrus and his team at Youngstown State University; Dr. Richard Carr and his team at Mississippi State University), is developing an extra-corporeal (out of the body) treatment against PTSD, CTE, Alzheimer's Disease and other virusses and diseases. With the use of antibodies the disease antigens is targeted. Using radiofrequency / laser technology the "antibody-metallic moiety-antigens complex" is destroyed/eradicated. All based on 4 granted patents and 22 pending provisional/non-provisional (some PCT) patent applications.
2024: In close cooperation with partner (revenue sharing agreement in place) AthenaGTX, Halberd Corp is working on contracts from the military, to develop treatments to tackle Traumatic Brain Injury/TBI (patent pending nasal spray) and Post Traumatic Stress Syndrome/PTSD (patented Low-Dose-Naltrexone product).
JACKSON CENTER, PA / ACCESSWIRE / March 14, 2023 / Halberd Corporation (OTC PINK:HALB) is scheduled to meet with Center of Disease Control (CDC) representatives to discuss Halberd's incredible success in eradicating multiple strains of antibiotic resistant (AR) E. coli bacteria and Candida auris samples previously provided by the CDC.
JACKSON CENTER, PA / ACCESSWIRE / September 6, 2023 / Halberd Corporation's (OTC PINK:HALB) research at Mississippi State University (MSU) has shown significant reduction in two key markers of traumatic brain injury (TBI) in early testing of Halberd's patent-pending nasal spray to mitigate the effects of TBI. Anecdotal data in preliminary testing reveals a 20% reduction in Neuron Specific Enolase and a 50% reduction in the levels of Glial Fibrillary Acid Protein compared to the control group.
JACKSON CENTER, PA / ACCESSWIRE / September 20, 2023 / Halberd Corporation (OTC PINK:HALB) and Athena GTX, Inc, of Johnston, Iowa commenced collaboration on critical development of submissions for government contracts seeking proposals for the detection and treatment of traumatic brain injury (TBI). The initial focus will be on accelerating and fine-tuning Halberd's proprietary nasal spray for suppressing the effects of traumatic brain injury (TBI).
JACKSON CENTER, PA / ACCESSWIRE / December 13, 2023 / Halberd Corporation (OTC PINK:HALB) and CrodenHealth.com of Canada agree to produce, market, sell and distribute Halberd's patented low dose naltrexone combo product(s) worldwide. The agreement also allows CrodenHealth.com right of first refusal regarding similar rights to future products in Halberd's development pipeline.
JACKSON CENTER, PA / ACCESSWIRE / January 10, 2024 / Halberd Corporation (OTC-PINK:HALB) is thrilled to declare the formalization of a profitable revenue-sharing accord with Athena GTX, Inc., of Johnston, Iowa, (www.athenagtx.com). Athena GTX is a private enterprise specializing in providing medical care solutions tailored for first responders in both civilian and government sectors.
Halberd's / Athena's treatment for PTSD is called WatchDawg
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |